Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;31(7):1284-1297.
doi: 10.1158/1055-9965.EPI-21-1440.

Epidemiology of Thyroid Cancer

Cari M Kitahara  1 , Arthur B Schneider  2
Affiliations

Epidemiology of Thyroid Cancer

Cari M Kitahara et al. Cancer Epidemiol Biomarkers Prev. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

None

Figures

Figure 1a-b.
Figure 1a-b.
Estimated age-standardized rates (ASR) for thyroid cancer incidence (a) and thyroid cancer mortality (b) worldwide. Data source and graph production: GLOBOCAN 2020, International Agency for Research on Cancer, World Health Organization (7).
Figure 2a-b.
Figure 2a-b.
Thyroid cancer incidence in U.S. men and women, by calendar year at diagnosis (SEER-9, 1975–2018) (a) and age at diagnosis (SEER-21, 2014–2018) (b), (all races). Data source and graph production: SEER, Bethesda, MD (11). 1Estimates based on <16 cases are suppressed.
Figure 3a-b.
Figure 3a-b.
Race/ethnicity differences in thyroid cancer incidence trends (SEER-21, 2000–2018, delay-adjusted) (a) and five-year relative survival by stage at diagnosis (SEER-18, 2011–2017) (b). Data source and graph production: SEER, Bethesda, MD (11). 1Estimates based on <16 cases are suppressed.
Figure 4.
Figure 4.
Trends in the incidence of papillary thyroid cancer in the U.S., overall and stratified by overweight and obesity-related and -unrelated cases, 1995–2015. The trend lines represent the incidence in each calendar-year period, and the gray bars represent the population-attributable fraction. Adapted from Kitahara et al., J Natl Cancer Inst 2020 (106).
See this image and copyright information in PMC

References

    1. Surveillance, Epidemiology, and End Results Program (SEER) Cancer Statistics Review, 1975–2018 [Internet]. Bethesda (MD): National Cancer Institute; 2021. Apr 15 [cited 2021 Nov 24]. Available from: http://seer.cancer.gov/csr/1975_2018.
    1. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014;159:676–90. - PMC - PubMed
    1. Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, et al. Integrated genomic analysis of Hurthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes. Cancer Cell 2018;34:256–70.e5. - PMC - PubMed
    1. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 2013;309:1493–501. - PMC - PubMed
    1. Romei C, Elisei R. A narrative review of genetic alterations in primary thyroid epithelial cancer. Int J Mol Sci 2021;22. - PMC - PubMed

Publication types